These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21763546)

  • 1. New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir.
    Darwich E; Darwich L; Cañadas MP; Klaustermeier J; Ercilla G; Alsina-Gibert M; Mascaró JM
    J Am Acad Dermatol; 2011 Aug; 65(2):e43-e45. PubMed ID: 21763546
    [No Abstract]   [Full Text] [Related]  

  • 2. No apparent effect of cidofovir in epidermodysplasia verruciformis.
    Preiser W; Kapur N; Snoeck R; Groves RW; Brink NS
    J Clin Virol; 2000 Feb; 16(1):55-7. PubMed ID: 10680741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1% topical cidofovir used as last alternative to treat viral infections.
    Briand S; Milpied B; Navas D; Thomare P; Stalder JF
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):249-50. PubMed ID: 18211429
    [No Abstract]   [Full Text] [Related]  

  • 4. Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
    Orlando G; Fasolo MM; Beretta R; Signori R; Adriani B; Zanchetta N; Cargnel A
    AIDS; 1999 Oct; 13(14):1978-80. PubMed ID: 10513659
    [No Abstract]   [Full Text] [Related]  

  • 5. Human immunodeficiency virus (HIV)-associated epidermodysplasia verruciformis eradicated after interferon-α and ribavirin treatment.
    Javelle E; Lightburne E; Dukan P; De Biasi C; Morand JJ
    Int J Dermatol; 2014 Apr; 53(4):487-9. PubMed ID: 24527965
    [No Abstract]   [Full Text] [Related]  

  • 6. Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy.
    Davis MD; Gostout BS; McGovern RM; Persing DH; Schut RL; Pittelkow MR
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):340-3. PubMed ID: 10901717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment.
    Di Lucca-Christment J; Jacobelli S; Gressier L; Plantier F; Laude H; Rozenberg F; Morini JP; Dallot A; Avril MF; Dupin N
    AIDS; 2012 Feb; 26(4):523-6. PubMed ID: 22210631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory human papillomavirus-associated oral warts treated topically with 1-3% cidofovir solutions in human immunodeficiency virus type 1-infected patients.
    Husak R; Zouboulis CC; Sander-Bähr C; Hummel M; Orfanos CE
    Br J Dermatol; 2005 Mar; 152(3):590-1. PubMed ID: 15787847
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study.
    Calista D
    J Eur Acad Dermatol Venereol; 2000 Nov; 14(6):484-8. PubMed ID: 11444271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cutaneous human papillomavirus infection by EVER2 gene mutation].
    Taghy A; Lamsyah H; Mahhou M; Sinae M; Hassam B
    Presse Med; 2014 Jun; 43(6 Pt 1):735-6. PubMed ID: 24630264
    [No Abstract]   [Full Text] [Related]  

  • 11. Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection.
    Martinelli C; Farese A; Mistro AD; Giorgini S; Ruffino I
    J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):568-9. PubMed ID: 11843219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel treatment of atypical human papillomavirus-associated epithelial hyperplasia with cidofovir.
    Collette DC; Zechel MA
    J Oral Maxillofac Surg; 2011 Sep; 69(9):2383-6. PubMed ID: 21292369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired epidermodysplasia verruciformis: clinical presentation and treatment update.
    Moore S; Rady P; Tyring S
    Int J Dermatol; 2022 Nov; 61(11):1325-1335. PubMed ID: 34403500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir.
    Calista D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):713-5. PubMed ID: 11113816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.
    Snoeck R; Bossens M; Parent D; Delaere B; Degreef H; Van Ranst M; Noël JC; Wulfsohn MS; Rooney JF; Jaffe HS; De Clercq E
    Clin Infect Dis; 2001 Sep; 33(5):597-602. PubMed ID: 11477525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of progressive outer retinal necrosis with cidofovir in a human immunodeficiency virus-infected patient.
    Schliefer K; Gümbel HO; Rockstroh JK; Spengler U
    Clin Infect Dis; 1999 Sep; 29(3):684-5. PubMed ID: 10530469
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of intravenous cidofovir for generalized verrucosis in a patient with severe combined immunodeficiency.
    Potthoff A; Wieland U; Kreuter A
    Arch Dermatol; 2012 May; 148(5):659-60. PubMed ID: 22782169
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidermodysplasia verruciformis-like eruption associated with HIV infection.
    Davison SC; Francis N; McLean K; Bunker CB
    Clin Exp Dermatol; 2004 May; 29(3):311-2. PubMed ID: 15115519
    [No Abstract]   [Full Text] [Related]  

  • 19. The management of oral human papillomavirus with topical cidofovir: a case report.
    DeRossi SS; Laudenbach J
    Cutis; 2004 Mar; 73(3):191-3. PubMed ID: 15074348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue.
    Snoeck R; Van Ranst M; Andrei G; De Clercq E; De Wit S; Poncin M; Clumeck N
    N Engl J Med; 1995 Oct; 333(14):943-4. PubMed ID: 7666893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.